微流控精子分选可筛选出具有更高受精潜力的高质量精子亚群
本研究于2023-2024年使用100份精液样本,比较新型微流控精子分选器(MSS)与密度梯度离心(DGC)和上游法(SU)分离高质量精子的效率。在正常精液组和非正常精液组中,MSS选出的精子前向运动率最高、PLCζ阳性表达及PLCζ和PAWP荧光强度最高、非前向运动率最低、DNA碎片最少,均优于DGC和SU法(P < 0.05)。
要点
- MSS选出的精子前向运动率、PLCζ阳性表达及PLCζ和PAWP荧光强度均最高,非前向运动率和DNA碎片最低(P < 0.05)。
- MSS芯片精子产量低,且研究有意排除严重男性因素不育,尚需在严重少精子症精液及低浓度低活力样本中测试。
- 因伦理限制,目前无法将MSS获得的精子用于临床评估受精率和进一步结局。
核心结论
- MSS选出的精子参数改善、DNA碎片更低且受精潜力更高。
- 微流控精子分选可能从原始精液中筛选出高质量精子,该新技术可能是改善不育患者辅助生殖临床结局的关键。
研究设计与样本
- 研究于2023-2024年使用100份精液样本,分两组比较新型MSS与DGC和SU法分离高质量精子的效率。
- 精液标本来自50名正常精液男性和50名非正常精液男性。
- 采用流式细胞术检测PLCζ和PAWP表达以评估受精潜力,并以染色质分散试验评估精子DNA损伤。
主要发现
- 在正常精液组和非正常精液组中,MSS选出的精子前向运动率最高、PLCζ阳性表达及PLCζ和PAWP荧光强度最高、非前向运动率最低、DNA碎片最少,均优于DGC和SU法(P < 0.05)。
局限性
- MSS芯片精子产量低。
- 研究有意排除严重男性因素不育以获得足够精子数进行分子实验,因此尚需在严重少精子症精液及低浓度低活力样本中测试。
- 因伦理考虑,目前无法将MSS获得的精子用于临床评估受精率和进一步结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is a microfluidic sperm sorter (MSS) able to select higher quality sperm compared to conventional methods? SUMMARY ANSWER: The MSS selects sperm with improved parameters, lower DNA fragmentation, and higher fertilizing potential. WHAT IS KNOWN ALREADY: To date, the few studies that have compared microfluidics sperm selection with conventional methods have used heterogeneous study population and have lacked molecular investigations. STUDY DESIGN, SIZE, DURATION: The efficiency of a newly designed MSS in isolating high-quality sperm was compared to the density-gradient centrifugation (DGC) and swim-up (SU) methods, using 100 semen samples in two groups, during 2023-2024. PARTICIPANTS/MATERIALS, SETTING, METHODS: Semen specimens from 50 normozoospermic and 50 non-normozoospermic men were sorted using MSS, DGC, and SU methods to compare parameters related to the quality and fertilizing potential of sperm. The fertilizing potential of sperm was determined by measurement of phospholipase C zeta (PLCζ) and post-acrosomal sheath WW domain-binding protein (PAWP) expression using flow cytometry, and the chromatin dispersion test was used to assess sperm DNA damage. MAIN RESULTS AND THE ROLE OF CHANCE: In both normozoospermic and non-normozoospermic groups, the MSS-selected sperm with the highest progressive motility, PLCζ positive expression and PLCζ and PAWP fluorescence intensity the lowest non-progressive motility, and minimal DNA fragmentation, compared to sperm selected by DGC and SU methods (P < 0.05). LIMITATION, REASONS FOR CAUTION: The major limitations of our study were the low yield of sperm in the MSS chips and intentional exclusion of severe male factor infertility to yield a sufficient sperm count for molecular experiments; thus testing with severe oligozoospermic semen and samples with low count and motility is still required. In addition, due to ethical considerations, at present, it was impossible to use the sperm achieved from MSS in the clinic to assess the fertilization rate and further outcomes. WIDER IMPLICATIONS OF THE FINDINGS: Our research presents new evidence that microfluidic sperm sorting may result in the selection of high-quality sperm from raw semen. This novel technology might be a key to improving clinical outcomes of assisted reproduction in infertile patients. STUDY FUNDING/COMPETING INTEREST(S): The study is funded by the Iran University of Medical Sciences and no competing interest exists. TRIAL REGISTRATION NUMBER: N/A.
引用
- Sheibak N, Amjadi F, Shamloo A, et al. Microfluidic sperm sorting selects a subpopulation of high-quality sperm with a higher potential for fertilization. Hum Reprod. 2024. PMID: 38461455. doi:10.1093/humrep/deae045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。